Suppr超能文献

沙格奈-圣安娜脑脊髓共济失调症是否为一种发育性疾病?

Is the ataxia of Charlevoix-Saguenay a developmental disease?

机构信息

Service of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.

出版信息

Med Hypotheses. 2011 Sep;77(3):347-52. doi: 10.1016/j.mehy.2011.05.011. Epub 2011 Jun 12.

Abstract

The autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is considered a neurodegenerative disease caused by mutations in the SACS gene, located on chromosome 13q12.12. It is a syndrome that comprises skeletal, retinal and neurological manifestations, among which feature spasticity, cerebellar ataxia and peripheral neuropathy. Five patients with a molecular diagnosis of ARSACS underwent clinical, radiological, and ophthalmologic examinations. Every one of the identified causal mutations was novel. Spastic ataxia, peripheral neuropathy, pes cavus, and hammertoes were found in every case. T2 and T2-fluid attenuation inversion recovery-weighted MRI sequences demonstrated cerebellar atrophy and a hypointense linear striation at the pons. Tensor diffusion sequences revealed that the hypointense striation corresponded with hyperplasia of the pontocerebellar fibres, which gave place to abnormally thick middle cerebellar peduncles. Stereophotographs of the optic discs showed an increased number of retinal fibres, and ocular coherence tomography, increased thickness of the retinal nerve fibre layer. The authors suggest that the hyperplasic pontocerebellar fibres compress the pyramidal tracts at the pons since a very early stage of central nervous system development, causing spasticity, and may also cause cerebellar atrophy by means of glutamate-induced excitotoxicity. The abnormal amount of retinal fibres traversing the optic discs could have caused the detected mild peripheral visual field defects. Taken together, these facts point to a developmental cause in ARSACS, as it does not exhibit the tissue atrophy characteristic of degenerative diseases. Clinical deterioration in ARSACS seems to be mediated by phenomena (compression of the pyramidal tracts and cerebellar glutamate-mediated excitotoxicity) derived from the developmental anomalies referred to, while the neuromuscular symptoms are caused by a peripheral neuropathy with pathologic features suggestive of a similar origin. These observations should be taken into account when research about the origin of ARSACS is undertaken.

摘要

查尔洛夫-萨格奈(Charlevoix-Saguenay)常染色体隐性痉挛性共济失调(ARSACS)被认为是一种神经退行性疾病,由位于 13q12.12 染色体上的 SACS 基因突变引起。该综合征包括骨骼、视网膜和神经表现,其中特征为痉挛性、小脑性共济失调和周围神经病。五名经分子诊断为 ARSACS 的患者接受了临床、放射学和眼科检查。确定的每个因果突变都是新的。每个病例都发现痉挛性共济失调、周围神经病、高弓足和槌状趾。T2 和 T2 液体衰减反转恢复加权 MRI 序列显示小脑萎缩和桥脑线性低信号条纹。张量扩散序列显示低信号条纹与桥脑小脑纤维增生相对应,导致异常增厚的小脑上脚。视盘的立体照片显示视网膜纤维数量增加,眼相干断层扫描显示视网膜神经纤维层增厚。作者认为,由于中枢神经系统发育的早期阶段,增生的桥脑小脑纤维压迫桥脑的锥体束,导致痉挛,并可能通过谷氨酸诱导的兴奋性毒性引起小脑萎缩。穿过视盘的异常数量的视网膜纤维可能导致检测到的轻度周边视野缺损。综上所述,这些事实表明 ARSACS 的发病原因是发育性的,因为它没有表现出退行性疾病的组织萎缩特征。ARSACS 的临床恶化似乎是由上述发育异常引起的现象(锥体束的压迫和小脑的谷氨酸介导的兴奋性毒性)介导的,而神经肌肉症状是由具有相似起源的病理特征的周围神经病引起的。在进行 ARSACS 起源的研究时,应该考虑到这些观察结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验